Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-Health Disparities Subcommittee (HDS), 19186 [2016-07527]
Download as PDF
19186
Federal Register / Vol. 81, No. 64 / Monday, April 4, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—Health Disparities
Subcommittee (HDS)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
Time and Date: 8:30 a.m.–4:30 p.m.,
EDT, April 28, 2016.
Place: CDC, Building 19, Rooms 256/
257, 1600 Clifton Road NE., Atlanta,
Georgia 30329.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 50
people. The public is welcome to
participate during the public comment
period, which is tentatively scheduled
from 4:00 p.m. to 4:15 p.m. This
meeting is also available by
teleconference. Please dial (866) 763–
0273 and enter code 6158968.
Purpose: The Subcommittee will
contribute to the ACD’s advice to the
CDC Director on strategic and other
health disparities and health equity
issues and provide guidance on
opportunities for CDC.
Matters for Discussion: The Health
Disparities Subcommittee members will
discuss progress toward the
Subcommittee’s input to the ACD on
disparity issues related to
environmental health.
The agenda is subject to change as
priorities dictate.
Web links:
Windows Media: https://
wm.onlinevideoservice.com/CDC1.
Flash: https://
www.onlinevideoservice.com/clients/
CDC/?mount=CDC3.
Smart Phones and Mobile devices:
https://
wowza01.sea.onlinevideoservice.com/
live/CDC3/playlist.m3u8.
If you are unable to connect using the
link, copy and paste the link into your
web browser.
Number for Technical Support: 404–
639–3737.
Contact Person for More Information:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600
Clifton Road, NE., M/S K–77, Atlanta,
Georgia 30329 Telephone (770) 488–
8343, Email: LEL1@cdc.gov.
VerDate Sep<11>2014
19:03 Apr 01, 2016
Jkt 238001
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–07527 Filed 4–1–16; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA), RFA–CE–16–003, Research on
Prescription Opioid Use, Opioid
Prescribing, and Associated Heroin
Risk.
Time and Date: 8:30 a.m.–5:00 p.m.,
EDT, April 27–28, 2016 (Closed).
Place: Atlanta Marriott Century
Center, 2000 Century Blvd. NE., Atlanta,
Georgia 30345.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Research on Prescription Opioid Use,
Opioid Prescribing, and Associated
Heroin Risk’’, FOA RFA–CE–16–003.
Contact Person for More Information:
M. Chris Langub, Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway NE., Mailstop F–80, Atlanta,
Georgia 30341, Telephone: (770) 488–
3585, EEO6@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
Frm 00075
Fmt 4703
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–07626 Filed 4–1–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sfmt 4703
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10:30 a.m.–5:00 p.m.,
EDT, April 28, 2016.
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public, but
without a public comment period. The
public is welcome to submit written
comments in advance of the meeting, to
the contact person below. Written
comments received in advance of the
meeting will be included in the official
record of the meeting. The public is also
welcome to listen to the meeting by
joining the teleconference at the USA
toll-free, dial-in number at 1–866–659–
0537 and the pass code is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
E:\FR\FM\04APN1.SGM
04APN1
Agencies
[Federal Register Volume 81, Number 64 (Monday, April 4, 2016)]
[Notices]
[Page 19186]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07527]
[[Page 19186]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention--Health Disparities Subcommittee (HDS)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
subcommittee:
Time and Date: 8:30 a.m.-4:30 p.m., EDT, April 28, 2016.
Place: CDC, Building 19, Rooms 256/257, 1600 Clifton Road NE.,
Atlanta, Georgia 30329.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 50 people. The public is
welcome to participate during the public comment period, which is
tentatively scheduled from 4:00 p.m. to 4:15 p.m. This meeting is also
available by teleconference. Please dial (866) 763-0273 and enter code
6158968.
Purpose: The Subcommittee will contribute to the ACD's advice to
the CDC Director on strategic and other health disparities and health
equity issues and provide guidance on opportunities for CDC.
Matters for Discussion: The Health Disparities Subcommittee members
will discuss progress toward the Subcommittee's input to the ACD on
disparity issues related to environmental health.
The agenda is subject to change as priorities dictate.
Web links:
Windows Media: https://wm.onlinevideoservice.com/CDC1.
Flash: https://www.onlinevideoservice.com/clients/CDC/?mount=CDC3.
Smart Phones and Mobile devices: https://wowza01.sea.onlinevideoservice.com/live/CDC3/playlist.m3u8.
If you are unable to connect using the link, copy and paste the
link into your web browser.
Number for Technical Support: 404-639-3737.
Contact Person for More Information: Leandris Liburd, Ph.D.,
M.P.H., M.A., Designated Federal Officer, Health Disparities
Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton
Road, NE., M/S K-77, Atlanta, Georgia 30329 Telephone (770) 488-8343,
Email: LEL1@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2016-07527 Filed 4-1-16; 8:45 am]
BILLING CODE 4163-18-P